SCHEMBL29396060

SCHEMBL29396060

COc1cc2c(c(O)c1OC)C(=O)c1c(cc(C)c(O)c1OC)C2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 4/20 1.00
▸ ELANE P08246 4/20 0.49
▸ PIM1 P11309 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ GRIN2D O15399 1/20 0.39
▸ GRIN3B O60391 1/20 0.39
▸ GRIN1 Q05586 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16226754 1.00 EPHX2 (1.00) EPHX2ELANEPIM1ALDH1A1CYP1A2
SCHEMBL31322006 1.00 EPHX2 (1.00) EPHX2ELANEPIM1ALDH1A1CYP1A2
SCHEMBL27927334 0.93 EPHX2 (0.86) EPHX2ELANEPIM1ALDH1A1CYP1A2
Chrysoobtusin SCHEMBL16226057 0.93 EPHX2 (1.00) EPHX2ELANEPIM1ALDH1A1CYP1A2
SCHEMBL16932396 0.88 EPHX2 (0.81) EPHX2ELANEPIM1ALDH1A1CYP1A2
SCHEMBL16226676 0.88 EPHX2 (0.86) EPHX2ELANEPIM1ALDH1A1CYP1A2
Aurantioobtusin SCHEMBL3189231 0.87 EPHX2 (0.76) EPHX2ELANEPIM1ALDH1A1MAPT
Aurantioobtusin SCHEMBL30643536 0.87 EPHX2 (0.76) EPHX2ELANEPIM1ALDH1A1MAPT
SCHEMBL28518188 0.84 EPHX2 (0.87) EPHX2ELANEPIM1ALDH1A1CYP1A2
SCHEMBL16226235 0.82 EPHX2 (0.76) EPHX2ELANEPIM1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119936249-A Feature map establishing method of abalone shell compound traditional Chinese medicine preparation 辽宁星晖药业科技有限公司 2025-05-06 — — CN claimed
CN-119406086-A Preparation process and method for extracting chrysophanol and aurantium obtusin from semen cassiae 安徽万花草保健品有限公司 2025-02-11 — — CN claimed
CN-115400164-B Special processing equipment for vision repairing liquid 宋文郡 2024-09-17 — — CN claimed
CN-118542895-A Ramulus mori extract composition for improving three highs 来宾市科技开发中心(来宾市技术市场管理中心) 2024-08-27 — — CN claimed
CN-118496080-A Juglandis Immaturus extract derivative, and preparation method and application thereof 井冈山大学 2024-08-16 — — CN claimed
CN-115184442-B Method for determining anthraquinone components by combining salting-out auxiliary liquid-liquid extraction and capillary electrophoresis on-line enrichment method 浙江工业大学 2024-05-03 — — CN claimed
CN-115792077-B Quality detection method of compound weight-losing and lipid-lowering oral liquid 江苏海洋大学 2024-01-02 — — CN claimed
CN-116672353-A Traditional Chinese medicine composition for enhancing phagocytic capacity of macrophages and preparation method thereof 浙江大学智能创新药物研究院 2023-09-01 — — CN claimed
CN-115561966-A Chemical amplification type negative photosensitive polyimide coating adhesive and application 明士(北京)新材料开发有限公司 2023-01-03 — — CN claimed
CN-115032305-A Method for detecting 7 anthraquinone compounds in cassia seeds by combining ultrasonic extraction of natural eutectic solvent with ultra-high performance liquid chromatography 南昌大学 2022-09-09 — — CN claimed
CN-114814004-A Cassia seed quality evaluation method based on plant metabonomics and spectrum effect relationship 浙江工业大学 2022-07-29 — — CN claimed
CN-114441582-A Detection and identification method for traditional Chinese medicine chemicals related to nuclear magnetic resonance equipment 泰州丹鼎生物科技有限公司 2022-05-06 — — CN claimed
US-11272711-B2 Antimicrobial and synergistic phytochemical composition, its preparation and applications PURPANA (BEIJING) TECHNOLOGIES CO., LTD. (CN) 2022-03-15 — — US claimed
CN-107917966-B Detection method of blood-nourishing brain-nourishing preparation 天士力医药集团股份有限公司 2022-02-18 — — CN claimed
CN-122031356-A Soluble micro-needle eye patch for relieving eye fatigue and preparation method thereof 辽宁星晖药业科技有限公司 2026-05-15 — — CN disclosed
CN-119936249-A Feature map establishing method of abalone shell compound traditional Chinese medicine preparation 辽宁星晖药业科技有限公司 2025-05-06 — — CN disclosed
CN-119909135-A Weishi brain-nourishing sustained-release tablet and preparation method thereof 杭州师范大学 2025-05-02 — — CN disclosed
CN-107917966-B Detection method of blood-nourishing brain-nourishing preparation 天士力医药集团股份有限公司 2022-02-18 — — CN disclosed
CN-110850019-B Method for detecting fingerprint of Minggu Shuqing drink 南京南医堂健康产业发展有限公司 2022-02-18 — — CN disclosed
CN-110604773-B Composition for regulating lipid metabolism disorder and preparation method and application thereof 四川科瑞欣医药科技有限公司 2022-02-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11272711-B2 Antimicrobial and synergistic phytochemical composition, its preparation and applications MANBA, MYB, NECTIN4 EPHX2 4796/4885ELANE 4491/4885PIM1 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback